These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34454570)

  • 1. Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.
    van Koningsbruggen-Rietschel S; Dunlevy F; Bulteel V; Hayes K; Verbrugge A; Janssens HM; Dufeu N; Simmonds NJ; Dupont LJ; Downey DG
    Trials; 2021 Aug; 22(1):578. PubMed ID: 34454570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).
    De Boeck K; Bulteel V; Tiddens H; Wagner T; Fajac I; Conway S; Dufour F; Smyth AR; Lee T; Sermet I; Kassai B; Elborn S;
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S67-74. PubMed ID: 21658644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation during critical illness affected by the COVID-19 pandemic.
    Reid JC; Molloy A; Strong G; Kelly L; O'Grady H; Cook D; Archambault PM; Ball I; Berney S; Burns KEA; D'Aragon F; Duan E; English SW; Lamontagne F; Pastva AM; Rochwerg B; Seely AJE; Serri K; Tsang JLY; Verceles AC; Reeve B; Fox-Robichaud A; Muscedere J; Herridge M; Thabane L; Kho ME;
    Trials; 2022 Sep; 23(1):735. PubMed ID: 36056378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials.
    Valmorri L; Vertogen B; Zingaretti C; Miserocchi A; Volpi R; Clemente A; Bondi I; Valli I; Rudnas B; Martinelli G; Nanni O
    BMC Med Res Methodol; 2021 Apr; 21(1):91. PubMed ID: 33931012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.
    Liu HH; Ezekowitz MD; Columbo M; Khan O; Martin J; Spahr J; Yaron D; Cushinotto L; Kapelusznik L
    Trials; 2021 Sep; 22(1):603. PubMed ID: 34493311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
    Mondejar-Lopez P; Moreno-Galarraga L; de Manuel-Gomez C; Blitz-Castro E; Bravo-Lopez M; Gartner S; Perez-Ruiz E; Caro-Aguilera P; Sanz-Santiago V; Lopez-Neyra A; Luna-Paredes C; Garcia-Gonzalez M; Costa-Colomer J; Cols-Roig M; Delgado-Pecellin I; Castillo-Corullon S; Ruiz de Valbuena-Maiz M; Garcia-Marcos PW; Aguilar-Fernandez AJ; Martin-De Vicente C; Barajas-Sanchez MV; Mesa-Medina O; Bover-Bauza C; Figuerola-Mulet J; Garcia-Aviles B; Rodriguez-Saez MJ; Garcia-Magan C; Juarez-Marruecos P; Gutierrez-Martinez JR; Cortell-Aznar I; Gomez-Pastrana D; Velasco-Gonzalez MV; Barrio MI; Sanchez-Solis M; Asensio de la Cruz O; Pastor-Vivero MD
    Pediatr Pulmonol; 2023 Nov; 58(11):3195-3205. PubMed ID: 37589420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial.
    Lai KSP; Watt C; Ionson E; Baruss I; Forchuk C; Sukhera J; Burhan AM; Vasudev A
    Trials; 2020 Jul; 21(1):648. PubMed ID: 32665041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
    Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
    Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
    Bhatt AS; Lindholm D; Nilsson A; Zaozerska N; Claggett BL; Vaduganathan M; Kosiborod MN; Lam CSP; Hernandez AF; Martinez FA; Inzucchi SE; Shah SJ; de Boer RA; Desai A; Jhund PS; Langkilde AM; Petersson M; McMurray JJV; Solomon SD
    Am Heart J; 2023 Sep; 263():133-140. PubMed ID: 37220822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19.
    Henderson M; Fidler S; Mothe B; Grinsztejn B; Haire B; Collins S; Lau JSY; Luba M; Sanne I; Tatoud R; Deeks S; Lewin SR
    J Int AIDS Soc; 2022 Feb; 25(2):e25882. PubMed ID: 35138683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.